Since the development of adverse ventricular remodeling after myocardial infarction is a strong predictor of mortality and heart failure [33], the association between Galectin 3 levels and left ventricular remodeling after myocardial infarction, previously proven by di Tano et al. [34], can be the basis of the higher risk of mortality observed in patients with higher levels of Galectin 3 in our study. Here, LGALS3 is linked to heart failure.